“…Threonine-290 Regulates Human PXR Nuclear Translocation Discussion PXR, a member of the nuclear receptor superfamily, was originally characterized as a xenobiotic-activated transcription factor that plays a key role in regulating the expression of genes encoding drugmetabolizing enzymes and drug transporters. It was subsequently found to potentiate various biologic effects associated with pharmacologic and toxicologic consequences-not only the metabolism and clearance of endobiotics and xenobiotics, including various therapeutic drugs and environmental endocrine disruptors, but also cancer pathogenesis (Timsit and Negishi, 2007;Staudinger and Lichti, 2008;Ihunnah et al, 2011;Pondugula and Mani, 2013) and hepatic energy metabolism including gluconeogenesis, the b-oxidation of fatty acids, and lipogenesis (Konno et al, 2008). PXR is activated by the binding of endogenous and exogenous xenobiotics to its ligand-binding domain and is then translocated to the nucleus in which it activates transcription by binding to the xenobiotic-response element in the promoter region of the target gene with RXR (Timsit and Negishi, 2007).…”